论文部分内容阅读
目的:主要是观察奥美拉挫联合血凝酶在上消化道出血中的一些应用研究。方法:从某医院选择上消化道出血的患者一共92例,并随机的分为两个组,分别为对照组与观察组,各46例。其中对照组仅仅只使用奥美拉挫进行治疗,观察组则在此基础之上再合并血凝酶进行治疗,然后分别的观察这两组的一些临床反应、止血的时间和相应的不良反应。结果:得出结果,其对照组的临床疗效很显然比观察组的临床疗效低(P<0.05);且其对照组的止血的时间比观察组的止血时间要长得多(P<0.05)。结论:奥美拉挫联合血凝酶在消化道出血中的疗效很好,且其止血的时间很短,不良反应也较少,安全性较强,在临床上的应用很广泛,是非常的值得被推广的。
Objective: To observe the application of omeprazole combined with hemagglutinin in upper gastrointestinal bleeding. Methods: A total of 92 patients with upper gastrointestinal bleeding selected from a hospital were randomly divided into two groups: control group and observation group, with 46 cases in each group. The control group only treated with Omeprazole treatment, the observation group was based on the combination of hemagglutination enzyme treatment, and then observed some of the two groups of clinical reactions, bleeding time and the corresponding adverse reactions. Results: The results showed that the clinical efficacy of the control group was significantly lower than that of the observation group (P <0.05), and the control group had a much longer bleeding time than the observation group (P <0.05) . Conclusion: Omeprazole combined with hemagglutinin in the treatment of gastrointestinal bleeding is very good, and the hemostatic time is very short, less adverse reactions, safety, and is widely used in clinical and is very Worth to be promoted.